A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib

Clinical trial NCT02487316 · WITHDRAWN

Trial details

NCT number: NCT02487316
Sponsor: Jun Zhu
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Anaplastic Large-Cell Lymphoma

Start date: 2015-07-01
Primary completion: 2017-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.